Cargando…

Dosing Considerations for Antibodies Against COVID-19

At present, no cure is available for COVID-19 but vaccines, antiviral drugs, immunoglobulins, or the combination of immunoglobulins with antiviral drugs have been suggested and are in clinical trials. The purpose of this paper is to discuss the role of a pharmacokinetic and viral load analysis as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tegenge, Million A., Mahmood, Iftekhar, Struble, Evi, Golding, Basil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705402/ https://www.ncbi.nlm.nih.gov/pubmed/33259037 http://dx.doi.org/10.1007/s40268-020-00330-3

Ejemplares similares

Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence
por: Mahmood, Iftekhar, et al.
Publicado: (2020)

Passive Immunoprophylaxis for the Protection of the Mother and Her Baby: Insights from In Vivo Models of Antibody Transport
por: Xu, Yanqun, et al.
Publicado: (2017)

Transplacental Transfer of Hepatitis B Neutralizing Antibody during Pregnancy in an Animal Model: Implications for Newborn and Maternal Health
por: Ma, Li, et al.
Publicado: (2014)

Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
por: Belov, Artur, et al.
Publicado: (2021)

Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
por: Madabushi, Rajanikanth, et al.
Publicado: (2022)

A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule
por: Mahmood, Iftekhar
Publicado: (2022)

Clinical Pharmacology of Antibody-Drug Conjugates
por: Mahmood, Iftekhar
Publicado: (2021)

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023)

A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey
por: Mahmood, Iftekhar
Publicado: (2021)

Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs)
por: Mahmood, Iftekhar
Publicado: (2021)

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
por: Kuemmel, Colleen, et al.
Publicado: (2019)

Considerations for vaccinating children against COVID-19
por: Hart, John D, et al.
Publicado: (2023)

Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
por: Mahmood, Iftekhar
Publicado: (2020)

A comparison of different methods for the first-in-pediatric dose selection
por: Mahmood, Iftekhar
Publicado: (2022)

Advancing the science of patient input throughout the regulatory decision‐making process
por: Tegenge, Million A., et al.
Publicado: (2017)

Interspecies Scaling of Antibody–Drug Conjugates (ADC) for the Prediction of Human Clearance
por: Mahmood, Iftekhar
Publicado: (2021)

Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
por: Struble, Evi B., et al.
Publicado: (2021)

Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations
por: Farshadpour, Fatemeh, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
por: Leung, Elizabeth, et al.
Publicado: (2021)

Major considerations in vaccinating children in Africa against COVID-19
por: Osakuade, Oluwanifemi Williams, et al.
Publicado: (2022)

Human Antibodies Can Cross Guinea Pig Placenta and Bind Its Neonatal Fc Receptor: Implications for Studying Immune Prophylaxis and Therapy during Pregnancy
por: Struble, Evi Budo, et al.
Publicado: (2012)

Vitamin D dosing considerations in COVID-19
por: Simonson, William
Publicado: (2020)

A Simple Method for the Prediction of Human Concentration–Time Profiles and Pharmacokinetics of Antibody–Drug Conjugates (ADC) from Rats or Monkeys
por: Mahmood, Iftekhar
Publicado: (2022)

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
por: Zhong, Lilin, et al.
Publicado: (2009)

Zika Virus Infection and Antibody Neutralization in FcRn Expressing Placenta and Engineered Cell Lines
por: Xu, Yanqun, et al.
Publicado: (2022)

Erratum to Vitamin D dosing considerations in COVID-19
por: Simonson, William
Publicado: (2021)

Evidence Gaps and Challenges in the Fight Against COVID-19 in Africa: Scoping Review of the Ethiopian Experience
por: Gudina, Esayas Kebede, et al.
Publicado: (2021)

The Role of Ionizing Radiation for Diagnosis and Treatment against COVID-19: Evidence and Considerations
por: Chalkia, Marina, et al.
Publicado: (2022)

Considerations of COVID-19 in Ophthalmology
por: Salvetat, Maria Letizia, et al.
Publicado: (2023)

Development and application of therapeutic antibodies against COVID-19
por: Ning, Lin, et al.
Publicado: (2021)

Nanoluciferase Reporter Zika Viruses as Tools for Assessing Infection Kinetics and Antibody Potency
por: Xu, Yanqun, et al.
Publicado: (2023)

Considerations for diagnostic COVID-19 tests
por: Vandenberg, Olivier, et al.
Publicado: (2020)

Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Peptides: When Is the Assessment of Certain Factors Warranted?
por: Mahmood, Iftekhar, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies
por: Leipold, Douglas, et al.
Publicado: (2018)

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
por: Shim, Hyunbo
Publicado: (2020)

Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms
por: Bayat, Maryam, et al.
Publicado: (2021)

Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients
por: Lucas, Andrew T., et al.
Publicado: (2019)

COVID-19: Neurological Considerations in Neonates and Children
por: Stafstrom, Carl E., et al.
Publicado: (2020)

Cardiovascular manifestations and treatment considerations in COVID-19
por: Kang, Yu, et al.
Publicado: (2020)

Coagulopathy of Dengue and COVID-19: Clinical Considerations
por: Islam, Amin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgpt62ue9jll38mha4qn31gm8d